Cellusion
Manufacturing induced pluripotent stem cell-derived corneal endothelial cells for bullous keratopathy therapy.
Launch date
Employees
Market cap
-
Enterprise valuation
$87—131m (Dealroom.co estimates Jun 2023.)
Tokyo Japan (HQ)
Authorizing premium user...